Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of ...

The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added ...

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...

By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...

An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

The first patient in the UK with advanced bowel cancer to receive a liver transplant after the disease spread to it has said ...

A young woman is cancer-free after undergoing the UK’s first liver transplant for advanced bowel cancer. Bianca Perea, a ...

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...